thymosin beta 4 vs bpc 157 BPC-157 / Beta-4 Nasal Spray BPC 157 vs TB 500

In February 2026, HHS Secretary Kennedy announced the expected reclassification of approximately 14 Category 2 peptides including GHK-Cu to Category 1, which would enable prescription compounding, though formal FDA rulemaking had not yet been completed at that time [1]

Metabolites were quantified by high performance liquid chromatography (HPLC) on the Shimadzu Prominence-i LC-2030C 3D Plus (GMI, Ramsey, Minnesota) according to Pfeiffer et al

I do think the results of that trial will provide some answers to the questions youve asked

It appears to modulate neurotransmitter systems, including dopamine and serotonin, and has shown efficacy in counteracting damage induced by various neurotoxins, suggesting potential applications in neurological conditions like Parkinson's disease and schizophrenia-like models

This mechanism complements the angiogenic and proliferative effects of the peptide, ensuring that new cells not only form but also reach the locations where they are needed

If you want to use it, you should ask a doctor first, especially if you're already sick or taking other medicines